Modulatory Impact of Adipose-Derived Mesenchymal Stem Cells of Ankylosing Spondylitis Patients on T Helper Cell Differentiation
Open Access
Abstract
The domination of pro-inflammatory Th subsets (Th1, Th17) is characteristic of ankylosing spondylitis (AS). Mesenchymal stem cells (MSC) were reported to normalize Th imbalance, but whether MSCs from AS adipose tissue (AS/ASCs) possess such properties is unknown. We examined AS/ASCs’ impact on Th-cell differentiation, using healthy donors ASCs (HD/ASCs) as a control. The assessment of the expression of transcription factors defining Th1 (T-bet), Th2 (GATA3), Th17 (RORc), and Treg (FoxP3) subsets by quantitative RT-PCR, the concentrations of subset-specific cytokines by ELISA, and Treg (CD4+CD25highFoxP3+) formation by flow cytometry, were performed in the co-cultures of ASCs with activated CD4+ T cells or peripheral blood mononuclear cells (PBMCs). AS/ASCs and HD/ASCs exerted similar immunomodulatory effects. Acting directly on CD4+ T cells, ASCs decreased the T-bet/GATA3 and RORc/FoxP3 ratios, diminished Treg formation, but increase IFNγ and IL-17AF production, while ASCs co-cultured with PBMCs enhanced Treg generation and reduced IFNγ release. ASCs failed to up-regulate the anti-inflammatory IL-10 and TGFβ. AS/ASCs’ impact on allogeneic and autologous PBMCs was similar. In conclusion, to shift Th differentiation to a functional anti-inflammatory direction, ASCs require accessory cell support, whereas their direct effect may be pro-inflammatory. Because ASCs neither inhibit IL-17AF nor up-regulate anti-inflammatory cytokines, their usefulness for AS patients’ treatment remains uncertain.Keywords
Funding Information
- Narodowym Centrum Nauki (2016/21/B/NZ5/00500)
This publication has 60 references indexed in Scilit:
- Increased IL-22- and IL-17A-Producing Mucosal-Associated Invariant T Cells in the Peripheral Blood of Patients With Ankylosing SpondylitisFrontiers in Immunology, 2018
- Whodunit? The Contribution of Interleukin (IL)-17/IL-22-Producing γδ T Cells, αβ T Cells, and Innate Lymphoid Cells to the Pathogenesis of SpondyloarthritisFrontiers in Immunology, 2018
- Immune cells involved in the pathogenesis of ankylosing spondylitisBiomedicine & Pharmacotherapy, 2018
- Axial spondyloarthritisThe Lancet, 2017
- Secukinumab efficacy in anti-TNF-naive and anti-TNF-experienced subjects with active ankylosing spondylitis: results from the MEASURE 2 StudyAnnals of the Rheumatic Diseases, 2017
- Role of Th1/Th2 cytokines in the diagnosis and prognostic evaluation of ankylosing spondylitisGenetics and Molecular Research, 2017
- The immune dysfunction in ankylosing spondylitis patientsBioScience Trends, 2017
- Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1Nature Communications, 2015
- T lymphocyte subset imbalances in patients contribute to ankylosing spondylitisExperimental and Therapeutic Medicine, 2014
- Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritidesArthritis & Rheumatism, 2008